The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,865,846 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on July 1, 2024. The funding will support the project "TARGETING NEUROIMMUNE AND EPITHELIAL SIGNALING FOR ECZEMA TREATMENT" through June 30, 2028. MGH, a leading academic medical center and research institution, will conduct biomedical research, including clinical trials and laboratory studies, to advance the understanding and treatment of eczema. The Military Medical Research and Development program supports a wide range of medical research initiatives to improve outcomes for military service members, veterans, and the general public.
Generated 1/28/25, 10:39 AM